Pages that link to "Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease"
Jump to navigation
Jump to search
The following pages link to Paclitaxel-Eluting Stent Versus Sirolimus-Eluting Stent For The Prevention Of Restenosis In Diabetic Patients With Coronary Artery Disease:
Displayed 2 items.
- Acronyms of Clinical Trial Names (← links)
- ISAR DIABETES (redirect page) (← links)